Figure 1
Study design and patient disposition in the GAUGUIN study. (A) Phase 1. (B) Phase 2. *One patient enrolled in phase 2 of GAUGUIN did not enter follow-up because of a new anti-leukemia therapy.
Study design and patient disposition in the GAUGUIN study. (A) Phase 1. (B) Phase 2. *One patient enrolled in phase 2 of GAUGUIN did not enter follow-up because of a new anti-leukemia therapy.
